Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

71

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

LSD analogue with potential for treating schizophrenia

Related Posts

PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells

PMP22 duplication dysregulates lipid homeostasis and pl...

40

Chloride deregulation and GABA depolarization in MTOR-related malformations of cortical development

Chloride deregulation and GABA depolarization in MTOR-r...

56

Design principles of gene circuits for longevity

Design principles of gene circuits for longevity

68